Exercise to improve outcomes in colorectal cancer patients
Official title: Aerobic Fitness or Muscle Mass Training to Improve Colorectal Cancer Outcome (AMICO). The Effects of Exercise on Chemotherapy Dose Modification and Progression Free Survival in Patients With Metastatic Colorectal Cancer
Run by Radboud University Medical Center · NCT04754672 · Data updated 2026-11-12
This study is testing whether aerobic and resistance exercise can help people with metastatic colorectal cancer feel better and handle chemotherapy without needing to change their treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 228 (estimated) |
| Sponsor | Radboud University Medical Center Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 13 sites ('s-Hertogenbosch and 12 other locations) |
| Status | Recruiting |
| Started | March 2, 2021 |
| Main results expected | March 2026 |
| Study ends | December 2026 |
| Registry record updated | November 18, 2023 |
| Trial ID | NCT04754672 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients with metastatic colorectal cancer who are scheduled for first-line palliative chemotherapy.
✕Probably not a fit
Patients with a life expectancy of less than six months or those unable to perform basic daily activities may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of aerobic and resistance exercise on patients with metastatic colorectal cancer undergoing palliative chemotherapy. It aims to determine whether exercise can reduce chemotherapy-related toxicity and prevent dose modifications, which are common in this patient population. The study will compare different types of exercise interventions to identify the optimal approach for enhancing physical fitness and quality of life during treatment. By exploring the relationship between exercise and cancer outcomes, the research seeks to provide evidence for integrating exercise into standard cancer care.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment outcomes and quality of life for colorectal cancer patients undergoing chemotherapy.
How similar studies have gone: Previous studies have shown positive effects of exercise on cancer treatment outcomes, but this specific approach is novel and aims to clarify optimal exercise prescriptions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * mCRC with indication for palliative chemotherapy * scheduled for treatment with first-line doublet or triplet chemotherapy, according to the national guideline * able and willing to give written informed consent. Exclusion Criteria: * life expectancy \<6 months * unable to perform basic activities of daily living such as walking or biking * presence of cognitive disorders or severe emotional instability (e.g., Schizophrenia, Alzheimer, alcohol addiction); * presence of other disabling co-morbidities that might hamper physical exercise (e.g. heart failure (NYHA classes 3 and 4), chronic obstructive pulmonary disease (COPD, gold 3 and 4), orthopaedic conditions and neurological disorders (e.g., hernia, paresis, amputation, active rheumatoid arthritis); * insufficient mastery of the Dutch language; * presence of serious cardiovascular or cardiopulmonary conditions (e.g. unstable angina, arrhythmia or valve disease) such that exercise safety is at risk, as judged by the treating physician. * Already participating in structured vigorous aerobic and/or resistance exercise ≥ 2 times per week comparable to our intervention
Where it's running
-
Jeroen Bosch Ziekenhuis
's-Hertogenbosch, Netherlands Recruiting -
Flevoziekenhuis
Almere Stad, Netherlands Recruiting -
Meander Medisch Centrum
Amersfoort, Netherlands Recruiting -
Ziekenhuis Amstelland
Amstelveen, Netherlands Recruiting -
Amsterdam UMC
Amsterdam, Netherlands Recruiting -
Netherlands Cancer Institute
Amsterdam, Netherlands Recruiting
Show 7 more locations
-
Rijnstate Ziekenhuis
Arnhem, Netherlands Recruiting -
Ziekenhuis Amphia
Breda, Netherlands Recruiting -
Catharina Ziekenhuis
Eindhoven, Netherlands Recruiting -
Spaarne Gasthuis
Hoofddorp, Netherlands Recruiting -
Radboudumc
Nijmegen, Netherlands Recruiting -
Canisius Wilhelmina Ziekenhuis
Nijmegen, Netherlands Recruiting -
Umcu
Utrecht, Netherlands Recruiting
Study contacts
- Study coordinator: Laurien M Buffart, PhD
- Email: laurien.buffart@radboudumc.nl
- Phone: +31243613674
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Digital follow-up care for colorectal cancer survivors
This study is testing a new digital follow-up care program for colorectal cancer survivors to see if it can better support their individual needs and improve their quality of life after treatment.
-
Observational study on young adult cancer survivors
This study looks at young adults who have survived cancer to see how their long-term health and quality of life are affected.
-
Knife-assisted full-thickness resection for rectal lesions in a multicenter setting
A multicenter study tests knife-assisted full-thickness resection (kFTR) to remove rectal lesions in adults and see how well it works and how safe it is.
-
Personalized 3D Bioprinted Colorectal Cancer Microenvironment Model
This study tests patient-derived, 3D-bioprinted cancer models that include tumor, fibroblast, and immune cells to see if they can better predict how colorectal cancer will respond to treatment.
-
Integrated genomic and clinical database for cancer biomarker discovery
Researchers are building a combined genomic and clinical database at Samsung Medical Center to test biomarkers for cancer diagnosis, treatment choice, and predicting how well treatments work.
-
Prehabilitation with Resistance, Aerobic, or Both Before Colorectal Surgery
Four pre-surgery exercise options (resistance, aerobic, both, or none) will be tested to see which best reduces complications after colorectal cancer surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.